# EGATEN

NDC: 0078-0937
Generic name: triclabendazole
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20190213

FDA application: NDA208711

## Active ingredients

- TRICLABENDAZOLE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0937"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0937
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5552884e-10ea-450c-9658-d3d4f33c946e